Abstract
Recombination was most important in the generation of new viral strains and in the increase of HIV diversity. There were more and more new HIV-1 strains. Not only circulating recombinant forms (CRFs) but also unique recombinant forms (URFs) have been reported around the world. CRF07_BC and CRF08_BC were the two predominant CRFs circulated in Yunnan Province, southwest China. In the present study, we identified two new HIV Type 1 unique (B/C) recombinant gorms in Yunnan Province by nucleotide sequencing in two halves of HIV genome. Although the genomic structures of the two B/C recombinants were different from previously identified CRFs (CRF07_BC and CRF08_BC) and URFs in Yunnan Pprovince, they have several common recombination sites with CRF07_BC and CRF08_BC.
Introduction
O
Genetic recombination was considered as one of the major mechanisms for HIV to acquire sequence diversity. It was most important in the generation of new viral strains and in the increase of HIV diversity. Now, at the Los Alamos HIV database web site (
Yunnan Province was thought to be an epicenter of HIV-1 epidemic in China where subtype B and subtype C were co-circulating in the early 1990s. 6,7 The co-circulation of subtype B and subtype C had resulted in the emergence of two circulating recombinant forms, CRF07_BC and CRF08_BC. 8,9 .Meanwhile, multiple unique B/C recombinant forms have been detected in Yunnan Province. In the present study, we have found two new HIV Type 1 unique (B/C) recombinant forms in Yunnan Province, China.
Materials and Methods
Plasma samples were obtained from two HIV-1 infected individuals living in Yunnan Province. They gave written consent for the use of their blood samples for research and publication. The detailed information of the two patients is listed in Table 1.
NA, not available.
Viral RNA was extracted from the stored plasma samples using high pure viral RNA kit (Roche) according to the manufacturer's protocol. For plasma sample 341 containing 17,963 RNA copies/ml, RNA was directly extracted. Sample 309 with low viral loads (2504 copies/ml) was concentrated by centrifugation at 23,000 g for 1 h at 4°C prior to the same extraction procedure. 10 RNA was collected from the spin columns and dissolved with Elution Buffer in a final volume of 50 μl. The extracted RNA was immediately reverse transcribed.
Reverse transcription of RNA to single-strand cDNA was performed using the SuperScript III according to the manufacture's instruction (Invitrogen, Carlsbad, CA). We used reverse primers 07Rev8 (5’-CCTARTGGGATGTGTACTTCT GAACTT-3’; nt 5,193–5219; HXB2 numbering) and 1.R3.B3R (5’-ACTACTTGAAGCACTCAAGGCAAGCTTTATTG-3’; nt 9,611–9,642;HXB2 numbering) to synthesize cDNA that served as templates for amplification of 4.4 kb 5’-half viral genome fragment and 4.7 kb 3’-half viral genome fragment. The RT reaction volume was 20 μl; 8 μl RNA, 1 μl dNTP(10 mM),0.25 μl Primer(20 pmol/μl), 3.75 μl DNase/RNase Free Water were mixed and incubated for 5 min at 65°C to denature the secondary structure of the RNA template. The tube was transferred to an ice cooler and incubated for at least 1 min. The contents of the tube were collected by brief centrifugation. Then 4 μl 5X First-Strand buffer, 1 μl DTT (100 mM), 1 μl RNaseOUT(40 U/μl), 1 μl Superscript III(200 U/μl) were added to the above reaction mixture. Tubes were then incubated at 50°C for 1 h. Then 1 μl SuperScript III was added to the mixture and the tubes were incubated for 1 h at 55°C for increasing the cDNA yield and transcription of difficult template. Finally, the reaction was inactivated and the RNA template digested. The cDNA was frozen at −80°C until further analysis or used immediately for PCR amplification.
Near-endpoint PCR was performed to generate 5’- and 3’-half viral genome fragments using specific primers. In a 20 μl reaction volume, PCR amplifications were performed in the presence of 1X High Fidelity Platinum PCR buffer, 2 mM MgSO4, 0.2 mM of each dNTP, 0.2 μM of each primer, and 0.025 U/μl Platinum Taq High Fidelity polymerase (Invitrogen). First round PCR primers for amplifying the 5’-half genome were 1.U5.B1F and 07Rev8. PCR reactions were performed in MicroAmp 96-well reaction plates as the following: one cycle of 94°C for 2 min, and three cycles of a denaturing step of 94°C for 30 s, an annealing step of 55°C for 1 min, an extension step of 68°C for 5 min, followed by 32 cycles of a denaturing step of 94°C for 15 s, an annealing step of 55°C for 30 s, an extension step of 68°C for 4.5 min, and a final extension of 10 min at 68°C. 1 μl first-round PCR product was added to the second-round PCR to generate the 5’-half genome with the primers Upper1A and Rev11. The second-round PCR conditions were the same as the first round. For amplification of the 3’-half genome, we used primers 07For7 and 2.R3.B6R as the first-round primers, and then used primers VIF1 and Low2c as the second-round primers. PCR conditions were the same as for amplification of the 5’-half genome. Second-round PCR products were run on a 1% TAE agarose gel to check for positive amplification. For one sample, two positive 5’-half genomes and two positive 3’-half genomes were chosen and subjected to direct sequencing. The nearly full-length genome sequence was assembled by overlapping the sequences of the two half genome fragments and merging them into one sequence. The primers for amplification of 3’- and 5’-half genome were available upon request.
The two nearly full-length sequences were aligned with the HIV-1 reference strains (
Results
The assembled nearly full-length genome sequences of samples 309 and 341 were analyzed using the HIV sequence Locator (
Phylogenetic analysis of the nearly full-length genomes demonstrated that the two patients 309 and 341 clustered with CRF07_BC, CRF08_BC, and subtype C reference strain C.IN.95IN21068 (Fig. 1). Meanwhile, they presented the minimum sequence distances with subtype C reference strain C.IN.95IN21068 that was the backbone of CRF07_BC and CRF08_BC. Interestingly, they were distantly related to the other three HIV-1 subtype C reference strains distributed in African countries and Brazil.

Neighbor-joining phylogenetic tree of nearly full-length genomes of samples 309 and 341. The neighbor-joining tree is constructed with the reference strains for HIV group M (subtypes A–D, F–H, J, and K) and circulating recombinant forms (CRFs) using MEGA 4.1. Values on the branches represent the percentage of 1000 bootstrap replicates and bootstrap values over 70% are shown in the tree. The two URFs_BC are marked with a solid circle. The scale bar indicates 2% nucleotide sequence divergence.
Bootscanning analysis was performed to elucidate the structures of the two nearly full-length HIV-1 sequences and recombination breakpoints. Bootscanning plots of the two nearly full-length genomes using the representative reference strains revealed that evidence of possible recombination events were detected (Fig. 2). The two genomes were composed of subtype C and several small segments of subtype B. It was very similar to both CRF07_BC and CRF08_BC.

Bootscanning analysis of nearly full-length sequences of two samples
Informative site analyses were performed to further scrutinize and define the recombination breakpoints. According to informative site analysis, there were two small subtype B segments within sample 309 and one small subtype B segments within sample 341 respectively. Both sample 309 and sample 341 used subtype C as a backbone that was identical to that of bootscanning analyses. The genomic maps were constructed using the Recombinant HIV-1 Drawing Tool according to informative sites (Fig. 3). Recombinant breakpoints were indicated in relation to HXB2. Sample 309 displayed two small subtype B segments as follow: one in pol (2882–3109), and one in vpr-tat1-rev1-vpu (5827–6190). It was similar that one small subtype B segment, in gag (1204–1840), was detected in sample 341. One common subtype B segment (nt 1204–1840) located in gag p24 was shared between sample 341 and CRF08_BC. Additionally, one common subtype B segment (nt 2882–3109) located in pol p51 appeared in both sample 309 and CRF08_BC. Moreover, one segment (nt 5827–6190) located in vpr-tat1-rev1-vpu was very similar to one segment of CRF07_BC. Interestingly, one subtype B segment appeared in both CRF07_BC and CRF08_BC at the right end of genomes within nef gene while it did not occur in samples 309 and 341.

Schematic representation of the mosaic structures of the nearly full-length genomes of two B/C recombinants
The phylogenetic trees of the subtype C insertion segments within sample 309 and 341 indicated that all the subtype C segments were closely related to subtype C reference strain from India with high bootstrap values (data not shown). All the subtype B segments within sample 309 and 341 clustered with subtype B reference strains (Fig. 4). But only the segment within 341 showed that it originated from subtype B-Thai reference RL42 from China. The other subtype B segments within sample 309 had uncertain origins because their lengths were too short to get high bootstrap values.

Phylogenetic relationship of subtype B segments within samples 309 and 341 to reference strains of subtype A, B, C, and J. The neighbor-joining tree is constructed using MEGA 4.1. Values at the nodes indicate the percent bootstraps in which the cluster to the right was supported. Bootstraps of 70% and higher only are shown. The scale bars are shown at bottom.
Discussion
In the present study, we identified two new HIV Type 1 unique (B/C) recombinant forms in Yunnan Province, China. The genomic structures of the two B/C recombinants were different from previously identified CRFs (CRF07_BC and CRF08_BC) and URFs in Yunnan province. McCutchan et al. 12 reported that CRF07_BC and CRF08_BC shared five precise B/C boundaries based on the precise mapping of recombinant breakpoints. The two B/C URFs also have several similar recombination sites with CRF07_BC and CRF08_BC. Moreover, the subtype C segments used as backbone of the two URFs were closely related to those of Indian origin and distinct from clade C viruses isolated in South America and Africa which was identical to that of CRF07_BC and CRF08_BC.
Up to now, several papers have reported that multiple forms of URFs are present in Yunnan Province, especially in Dehong Prefecture. 13 –15 The patients whose plasma samples were used in this study were also living in Dehong Prefecture. The two new UFRs identified in this study reconfirmed the high prevalence of multiple forms of UFRs in Dehong Prefecture near the Myanmar border. 14,16 Most of previously identified UFRs were detected in IDUs, whereas in our study, one URFs was detected in patient 309 who was infected by heterosexual behavior. It suggested that the distribution of multiple forms of UFRs was not constrained to particular people with special high risk. In other words, not only IDUs but also people with other high risks were exposed to various UFRs to some extent.
HIV recombinants are an important and dynamic component of the global epidemic. The emergence of multiple forms URFs will undoubtedly baffle the development of effective vaccine. In Yang's article, he claimed that multiple forms of HIV-1 BC recombinants emerged in Yunnan Province with an on-going trend. 14 The two new BC URFs identified in this study had different genomic structures from all URFs reported in other papers. This obviously added the variety of HIV genome in Yunnan Province and may complicate the design of HIV vaccine. Although multiple forms of URFs were present in Yunnan Province, there was a lack of sufficient sequence data on the HIV-1 nearly full-length genome in this region. Most sequences obtained in this area were partial regions of the HIV-1 genome. It was necessary to increase the number of HIV-1 nearly full-length genomes to better elucidate the genotyping, prevalence, and evolution of HIV-1 in this region.
Sequence Data
Sequences have been submitted to GenBank under accession numbers: HM776938 and HM776939.
Footnotes
Acknowledgments
This work was supported by the National Key S&T Special Projects on Major Infectious Diseases (Grant Nos.2008ZX10001-004, 2008ZX10001-012). We also acknowledge Dr. Feng Gao at the Duke Human Vaccine Institute, Duke University Medical Center, for providing the technical support in achieving nearly full-length HIV genome.
Author Disclosure Statement
No competing financial interests exist.
